Glaucoma medications and ocular surface disease
3 August 2023
| Su Young
|
EYE - Glaucoma
|
Drug allergy, OSD, drug toxicity, drug-induced cicatricial keratitis, dry eye, glaucoma medications, ocular surface disease
This literature review examined ocular surface disease (OSD) associated with glaucoma medication. The authors examined the prevalence of features and management guidelines glaucoma medication associated OSD. Fifty-eight articles published within the past five years are included in this review and...
Microbiology, risk factors and outcomes of microbial keratitis in Sydney, Australia
5 February 2020
| Kurt Spiteri Cornish
|
EYE - Cornea, EYE - General
|
Microbial keratitis, cornea, dry eye, keratitis, ocular surface disease
The authors present a retrospective case series including all patients with microbial keratitis and ocular surface diseases (OSD), including dry eye, blepharitis, Stevens-Johnson syndrome and / or ocular cicatricial pemphigoid, over a five-year period between 2012 and 2016. A total...
Management of diffuse OSSN with topical chemotherapy
1 June 2015
| Anjali Gupta
|
Paediatric Ophthalmology / Strabismus
|
chemotherapy, complication, ocular surface squamous neoplasia
Ocular surface squamous neoplasia (OSSN) can be localised to the conjunctiva or, less commonly, diffusely spread over the conjunctiva and cornea. Localised OSSN can be treated by surgical removal with adjuvant cryotherapy and chemotherapy with low rates of recurrence. Diffuse...
Adjunctive topical 5-FU vs. MMC for surgically excised, localised OSSN
1 October 2014
| Anjali Gupta
|
EYE - Cornea, EYE - General
|
OSSN, chemotherapy, ocular oncology, ocular surface tumours
Ocular surface squamous neoplasia (OSSN) comprises a range of dysplasia including corneal-conjunctival intraepithelial neoplasia and invasive squamous cell carcinoma. The traditional treatment for localised non-invasive OSSN has been surgical excision with or without intraoperative cryotherapy. Postoperative adjunctive topical chemotherapy significantly...
